1 year return (CAGR)
-42.92%
Genelux Corporation Common Stock Exchange (NASDAQ, USD)
GNLX
2.54
-0.06 (-2.31%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-53.02%
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
114.92M
Price/Sales
14365.39
Ent value
115.83M
Price/Book
7.13
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
8.43%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.58 |
| Daily high | 2.63 |
| Daily low | 2.52 |
| Daily Volume | 77K |
| All-time high | 38.00 |
| 1y analyst estimate | 18.83 |
| Beta | 0.56 |
| EPS (TTM) | -0.75 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 6 Apr 2026 |
Downside potential
Loading...
Downside potential data
| GNLX | S&P500 | |
| Current price drop from All-time high | -93.32% | -1.06% |
| Highest price drop | -95.74% | -56.47% |
| Date of highest drop | 5 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -74.83% | -10.67% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 827 days | 1805 days |
News
